Rarebreed (PRIVATE.RAREBREED)

Overall impact
A (81)

Commentary

Rarebreed is a leader for overall positive impact. With an 'A' rating of 80.6 for overall impact (95th percentile compared to all companies), Rarebreed ranks 7th out of 71 industry peers, behind Elekta, COMPASS Pathways, Fleury SA and 3 others, and ahead of ModivCare, Ontrak, Hanger and 61 others. On top material causes for Rarebreed's industry (Healthcare Providers), Rarebreed performs well in Access to Affordable Healthcare (95.9 score), Accountable Institutions (80.9), Child and Maternal Health (96.0) and 10 other causes where it received an 'A' score and performs poorly in Quality Lifelong Education (29.2 score).
Impact
Cause PRIVATE.RAREBREED
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2018
Employees
800
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Gas Utilities & Distributors
Headquarters
Maine, United States
Share classes
PRIVATE.RAREBREED
Description
Operator of a partnership firm intended to serve the veterinary industry. The company offers learning tools, mentorship programs, employee assistance, yearly allowance and free degradation courses, pet medical benefits and healthcare benefits, thereby helping their clients to break the pattern of isolation in their profession.
Material causes
Ethos considers the following causes material for Rarebreed, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.